Disclosed are negative allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with glutamate dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
本发明涉及代谢型谷
氨酸受体亚型5(mGluR5)的负性变构调节剂;用于制备该化合物的合成方法;包含该化合物的药物组合物;以及使用该化合物和组合物治疗与谷
氨酸功能失调相关的神经和精神障碍的方法。本摘要旨在作为搜索特定领域的扫描工具,不限制本发明的范围。